These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 21045690)

  • 41. Ethnicity delineates different genetic pathways in malignant glioma.
    Chen P; Aldape K; Wiencke JK; Kelsey KT; Miike R; Davis RL; Liu J; Kesler-Diaz A; Takahashi M; Wrensch M
    Cancer Res; 2001 May; 61(10):3949-54. PubMed ID: 11358811
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Breast-cancer stromal cells with TP53 mutations and nodal metastases.
    Patocs A; Zhang L; Xu Y; Weber F; Caldes T; Mutter GL; Platzer P; Eng C
    N Engl J Med; 2007 Dec; 357(25):2543-51. PubMed ID: 18094375
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predicting the oncogenicity of missense mutations reported in the International Agency for Cancer Research (IARC) mutation database on p53.
    Gorlov IP; Gorlova OY; Amos CI
    Hum Mutat; 2005 Nov; 26(5):446-54. PubMed ID: 16173033
    [TBL] [Abstract][Full Text] [Related]  

  • 44. TP53 and mutations in human cancer.
    Szymańska K; Hainaut P
    Acta Biochim Pol; 2003; 50(1):231-8. PubMed ID: 12673364
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Somatic Nature of Cancer Allows It to Affect Highly Constrained Genes.
    Ostrow SL; Hershberg R
    Genome Biol Evol; 2016 Jun; 8(5):1614-20. PubMed ID: 27190005
    [TBL] [Abstract][Full Text] [Related]  

  • 46. p53: from molecular mechanisms to prognosis in cancer.
    Fung CY; Fisher DE
    J Clin Oncol; 1995 Apr; 13(4):808-11. PubMed ID: 7707105
    [No Abstract]   [Full Text] [Related]  

  • 47. Locus-specific mutation databases: pitfalls and good practice based on the p53 experience.
    Soussi T; Ishioka C; Claustres M; Béroud C
    Nat Rev Cancer; 2006 Jan; 6(1):83-90. PubMed ID: 16397528
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Counterpoints in cancer: the somatic mutation theory under attack.
    Thomas D; Moore A
    Bioessays; 2011 May; 33(5):313-4. PubMed ID: 21503932
    [No Abstract]   [Full Text] [Related]  

  • 49. Mutation order affects cancer behavior.
    Cancer Discov; 2015 May; 5(5):OF6. PubMed ID: 25762521
    [No Abstract]   [Full Text] [Related]  

  • 50. On somatic mutations and tissue fields in cancer: additional observations challenge the SMT.
    Satgé D
    Bioessays; 2011 Dec; 33(12):922-3. PubMed ID: 22113741
    [No Abstract]   [Full Text] [Related]  

  • 51. Genetic Markers in Triple-Negative Breast Cancer.
    Sporikova Z; Koudelakova V; Trojanec R; Hajduch M
    Clin Breast Cancer; 2018 Oct; 18(5):e841-e850. PubMed ID: 30146351
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunohistochemistry of p53 surrogates
    Kurihara Y; Honda T; Takemoto A; Seto K; Endo S; Tanimoto K; Kirimura S; Kobayashi M; Baba S; Nakashima Y; Wakejima R; Sakakibara R; Ishibashi H; Inazawa J; Tanaka T; Miyazaki Y; Okubo K
    JTCVS Open; 2024 Aug; 20():183-193. PubMed ID: 39296452
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Structured testing of genetic association with mixed clinical outcomes.
    Liu M; Su YR; Liu Y; Hsu L; He Q
    Genet Epidemiol; 2024 Apr; ():. PubMed ID: 38606632
    [TBL] [Abstract][Full Text] [Related]  

  • 54. USP19 Negatively Regulates p53 and Promotes Cervical Cancer Progression.
    Tyagi A; Karapurkar JK; Colaco JC; Sarodaya N; Antao AM; Kaushal K; Haq S; Chandrasekaran AP; Das S; Singh V; Hong SH; Suresh B; Kim KS; Ramakrishna S
    Mol Biotechnol; 2024 Aug; 66(8):2032-2045. PubMed ID: 37572221
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Unraveling the Pivotal Network of Ultrasound and Somatic Mutations in Triple-Negative and Non-Triple-Negative Breast Cancer.
    Huang Y; Guo Y; Xiao Q; Liang S; Yu Q; Qian L; Zhou J; Le J; Pei Y; Wang L; Chang C; Chen S; Zhou S
    Breast Cancer (Dove Med Press); 2023; 15():461-472. PubMed ID: 37456987
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differences in DNA damage repair gene mutations between left- and right-sided colorectal cancer.
    Huang W; Li W; Xu N; Li H; Zhang Z; Zhang X; He T; Yao J; Xu M; He Q; Guo L; Zhang S
    Cancer Med; 2023 May; 12(9):10187-10198. PubMed ID: 37096801
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clustering Sparse Data With Feature Correlation With Application to Discover Subtypes in Cancer.
    Qiang J; Ding W; Kuijjer M; Quackenbush J; Chen P
    IEEE Access; 2020; 8():67775-67789. PubMed ID: 36329870
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    Xue D; Lin H; Lin L; Wei Q; Yang S; Chen X
    Transl Cancer Res; 2021 Mar; 10(3):1284-1294. PubMed ID: 35116455
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Olaparib effectively treats local recurrence of extrahepatic cholangiocarcinoma in a patient harboring a
    Li W; Ma Z; Fu X; Hao Z; Shang H; Shi J; Lei M; Xu M; Ning S; Hua X
    Ann Transl Med; 2021 Sep; 9(18):1487. PubMed ID: 34734039
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Multifaceted Glioblastoma: From Genomic Alterations to Metabolic Adaptations.
    Quinones A; Le A
    Adv Exp Med Biol; 2021; 1311():59-76. PubMed ID: 34014534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.